Global Orally Disintegrating Tablet Market Growth 2020-2025

Publication Month: May 2020 | No. of Pages: 165 Published By:
Single User License: US $ 3660
Corporate User License: US $ 7320

According to this study, over the next five years the Orally Disintegrating Tablet market will register a 10.6% CAGR in terms of revenue, the global market size will reach $ 19870 million by 2025, from $ 13260 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Orally Disintegrating Tablet business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Orally Disintegrating Tablet market by type, application, key manufacturers and key regions and countries.

This study considers the Orally Disintegrating Tablet value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Anti-Psychotics Drug
Anti-Epileptics Drug
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva
Bristol-Myers Squibb
Merck
Pfizer
Johnson and Johnson
Mylan
Eli Lilly and Company
GSK
AstraZeneca
Otsuka
Conquer

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Orally Disintegrating Tablet consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Orally Disintegrating Tablet market by identifying its various subsegments.
Focuses on the key global Orally Disintegrating Tablet manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Orally Disintegrating Tablet with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Orally Disintegrating Tablet submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Orally Disintegrating Tablet Consumption 2015-2025
2.1.2 Orally Disintegrating Tablet Consumption CAGR by Region
2.2 Orally Disintegrating Tablet Segment by Type
2.2.1 Anti-Psychotics Drug
2.2.2 Anti-Epileptics Drug
2.2.3 Others
2.3 Orally Disintegrating Tablet Consumption by Type
2.3.1 Global Orally Disintegrating Tablet Consumption Market Share by Type (2015-2020)
2.3.2 Global Orally Disintegrating Tablet Revenue and Market Share by Type (2015-2020)
2.3.3 Global Orally Disintegrating Tablet Sale Price by Type (2015-2020)
2.4 Orally Disintegrating Tablet Segment by Application
2.4.1 CNS Diseases
2.4.2 Gastrointestinal Diseases
2.4.3 CVS Diseases
2.4.4 Others
2.5 Orally Disintegrating Tablet Consumption by Application
2.5.1 Global Orally Disintegrating Tablet Consumption Market Share by Type (2015-2020)
2.5.2 Global Orally Disintegrating Tablet Value and Market Share by Type (2015-2020)
2.5.3 Global Orally Disintegrating Tablet Sale Price by Type (2015-2020)

3 Global Orally Disintegrating Tablet by Company
3.1 Global Orally Disintegrating Tablet Sales Market Share by Company
3.1.1 Global Orally Disintegrating Tablet Sales by Company (2018-2020)
3.1.2 Global Orally Disintegrating Tablet Sales Market Share by Company (2018-2020)
3.2 Global Orally Disintegrating Tablet Revenue Market Share by Company
3.2.1 Global Orally Disintegrating Tablet Revenue by Company (2018-2020)
3.2.2 Global Orally Disintegrating Tablet Revenue Market Share by Company (2018-2020)
3.3 Global Orally Disintegrating Tablet Sale Price by Company
3.4 Global Orally Disintegrating Tablet Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Orally Disintegrating Tablet Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Orally Disintegrating Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Orally Disintegrating Tablet by Regions
4.1 Orally Disintegrating Tablet by Regions
4.2 Americas Orally Disintegrating Tablet Consumption Growth
4.3 APAC Orally Disintegrating Tablet Consumption Growth
4.4 Europe Orally Disintegrating Tablet Consumption Growth
4.5 Middle East & Africa Orally Disintegrating Tablet Consumption Growth

5 Americas
5.1 Americas Orally Disintegrating Tablet Consumption by Countries
5.1.1 Americas Orally Disintegrating Tablet Consumption by Countries (2015-2020)
5.1.2 Americas Orally Disintegrating Tablet Value by Countries (2015-2020)
5.2 Americas Orally Disintegrating Tablet Consumption by Type
5.3 Americas Orally Disintegrating Tablet Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Orally Disintegrating Tablet Consumption by Regions
6.1.1 APAC Orally Disintegrating Tablet Consumption by Regions (2015-2020)
6.1.2 APAC Orally Disintegrating Tablet Value by Regions (2015-2020)
6.2 APAC Orally Disintegrating Tablet Consumption by Type
6.3 APAC Orally Disintegrating Tablet Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Orally Disintegrating Tablet by Countries
7.1.1 Europe Orally Disintegrating Tablet Consumption by Countries (2015-2020)
7.1.2 Europe Orally Disintegrating Tablet Value by Countries (2015-2020)
7.2 Europe Orally Disintegrating Tablet Consumption by Type
7.3 Europe Orally Disintegrating Tablet Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Orally Disintegrating Tablet by Countries
8.1.1 Middle East & Africa Orally Disintegrating Tablet Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Orally Disintegrating Tablet Value by Countries (2015-2020)
8.2 Middle East & Africa Orally Disintegrating Tablet Consumption by Type
8.3 Middle East & Africa Orally Disintegrating Tablet Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Orally Disintegrating Tablet Distributors
10.3 Orally Disintegrating Tablet Customer

11 Global Orally Disintegrating Tablet Market Forecast
11.1 Global Orally Disintegrating Tablet Consumption Forecast (2021-2025)
11.2 Global Orally Disintegrating Tablet Forecast by Regions
11.2.1 Global Orally Disintegrating Tablet Forecast by Regions (2021-2025)
11.2.2 Global Orally Disintegrating Tablet Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Orally Disintegrating Tablet Forecast by Type
11.8 Global Orally Disintegrating Tablet Forecast by Application

12 Key Players Analysis
12.1 Teva
12.1.1 Company Information
12.1.2 Orally Disintegrating Tablet Product Offered
12.1.3 Teva Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Teva Latest Developments
12.2 Bristol-Myers Squibb
12.2.1 Company Information
12.2.2 Orally Disintegrating Tablet Product Offered
12.2.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Bristol-Myers Squibb Latest Developments
12.3 Merck
12.3.1 Company Information
12.3.2 Orally Disintegrating Tablet Product Offered
12.3.3 Merck Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Merck Latest Developments
12.4 Pfizer
12.4.1 Company Information
12.4.2 Orally Disintegrating Tablet Product Offered
12.4.3 Pfizer Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Johnson and Johnson
12.5.1 Company Information
12.5.2 Orally Disintegrating Tablet Product Offered
12.5.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Johnson and Johnson Latest Developments
12.6 Mylan
12.6.1 Company Information
12.6.2 Orally Disintegrating Tablet Product Offered
12.6.3 Mylan Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mylan Latest Developments
12.7 Eli Lilly and Company
12.7.1 Company Information
12.7.2 Orally Disintegrating Tablet Product Offered
12.7.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Eli Lilly and Company Latest Developments
12.8 GSK
12.8.1 Company Information
12.8.2 Orally Disintegrating Tablet Product Offered
12.8.3 GSK Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 GSK Latest Developments
12.9 AstraZeneca
12.9.1 Company Information
12.9.2 Orally Disintegrating Tablet Product Offered
12.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 AstraZeneca Latest Developments
12.10 Otsuka
12.10.1 Company Information
12.10.2 Orally Disintegrating Tablet Product Offered
12.10.3 Otsuka Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Otsuka Latest Developments
12.11 Conquer
12.11.1 Company Information
12.11.2 Orally Disintegrating Tablet Product Offered
12.11.3 Conquer Orally Disintegrating Tablet Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Conquer Latest Developments

13 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Orally Disintegrating Tablet Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Anti-Psychotics Drug
Table 5. Major Players of Anti-Epileptics Drug
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Orally Disintegrating Tablet Consumption Market Share by Type (2015-2020)
Table 9. Global Orally Disintegrating Tablet Revenue by Type (2015-2020) ($ million)
Table 10. Global Orally Disintegrating Tablet Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Orally Disintegrating Tablet Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Orally Disintegrating Tablet Consumption Market Share by Application (2015-2020)
Table 14. Global Orally Disintegrating Tablet Value by Application (2015-2020)
Table 15. Global Orally Disintegrating Tablet Value Market Share by Application (2015-2020)
Table 16. Global Orally Disintegrating Tablet Sale Price by Application (2015-2020)
Table 17. Global Orally Disintegrating Tablet Sales by Company (2017-2019) (M Units)
Table 18. Global Orally Disintegrating Tablet Sales Market Share by Company (2017-2019)
Table 19. Global Orally Disintegrating Tablet Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Orally Disintegrating Tablet Revenue Market Share by Company (2017-2019)
Table 21. Global Orally Disintegrating Tablet Sale Price by Company (2017-2019)
Table 22. Global Orally Disintegrating Tablet Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Orally Disintegrating Tablet Products Offered
Table 24. Orally Disintegrating Tablet Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Orally Disintegrating Tablet Consumption by Regions 2015-2020 (M Units)
Table 26. Global Orally Disintegrating Tablet Consumption Market Share by Regions 2015-2020
Table 27. Global Orally Disintegrating Tablet Value by Regions 2015-2020 ($ Millions)
Table 28. Global Orally Disintegrating Tablet Value Market Share by Regions 2015-2020
Table 29. Americas Orally Disintegrating Tablet Consumption by Countries (2015-2020) (M Units)
Table 30. Americas Orally Disintegrating Tablet Consumption Market Share by Countries (2015-2020)
Table 31. Americas Orally Disintegrating Tablet Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Orally Disintegrating Tablet Value Market Share by Countries (2015-2020)
Table 33. Americas Orally Disintegrating Tablet Consumption by Type (2015-2020) (M Units)
Table 34. Americas Orally Disintegrating Tablet Consumption Market Share by Type (2015-2020)
Table 35. Americas Orally Disintegrating Tablet Consumption by Application (2015-2020) (M Units)
Table 36. Americas Orally Disintegrating Tablet Consumption Market Share by Application (2015-2020)
Table 37. APAC Orally Disintegrating Tablet Consumption by Countries (2015-2020) (M Units)
Table 38. APAC Orally Disintegrating Tablet Consumption Market Share by Countries (2015-2020)
Table 39. APAC Orally Disintegrating Tablet Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Orally Disintegrating Tablet Value Market Share by Regions (2015-2020)
Table 41. APAC Orally Disintegrating Tablet Consumption by Type (2015-2020) (M Units)
Table 42. APAC Orally Disintegrating Tablet Consumption Market Share by Type (2015-2020)
Table 43. APAC Orally Disintegrating Tablet Consumption by Application (2015-2020) (M Units)
Table 44. APAC Orally Disintegrating Tablet Consumption Market Share by Application (2015-2020)
Table 45. Europe Orally Disintegrating Tablet Consumption by Countries (2015-2020) (M Units)
Table 46. Europe Orally Disintegrating Tablet Consumption Market Share by Countries (2015-2020)
Table 47. Europe Orally Disintegrating Tablet Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Orally Disintegrating Tablet Value Market Share by Countries (2015-2020)
Table 49. Europe Orally Disintegrating Tablet Consumption by Type (2015-2020) (M Units)
Table 50. Europe Orally Disintegrating Tablet Consumption Market Share by Type (2015-2020)
Table 51. Europe Orally Disintegrating Tablet Consumption by Application (2015-2020) (M Units)
Table 52. Europe Orally Disintegrating Tablet Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Orally Disintegrating Tablet Consumption by Countries (2015-2020) (M Units)
Table 54. Middle East & Africa Orally Disintegrating Tablet Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Orally Disintegrating Tablet Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Orally Disintegrating Tablet Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Orally Disintegrating Tablet Consumption by Type (2015-2020) (M Units)
Table 58. Middle East & Africa Orally Disintegrating Tablet Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Orally Disintegrating Tablet Consumption by Application (2015-2020) (M Units)
Table 60. Middle East & Africa Orally Disintegrating Tablet Consumption Market Share by Application (2015-2020)
Table 61. Orally Disintegrating Tablet Distributors List
Table 62. Orally Disintegrating Tablet Customer List
Table 63. Global Orally Disintegrating Tablet Consumption Forecast by Countries (2021-2025) (M Units)
Table 64. Global Orally Disintegrating Tablet Consumption Market Forecast by Regions
Table 65. Global Orally Disintegrating Tablet Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Orally Disintegrating Tablet Value Market Share Forecast by Regions
Table 67. Global Orally Disintegrating Tablet Consumption Forecast by Type (2021-2025) (M Units)
Table 68. Global Orally Disintegrating Tablet Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Orally Disintegrating Tablet Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Orally Disintegrating Tablet Value Market Share Forecast by Type (2021-2025)
Table 71. Global Orally Disintegrating Tablet Consumption Forecast by Application (2021-2025) (M Units)
Table 72. Global Orally Disintegrating Tablet Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Orally Disintegrating Tablet Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Orally Disintegrating Tablet Value Market Share Forecast by Application (2021-2025)
Table 75. Teva Product Offered
Table 76. Teva Orally Disintegrating Tablet Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. Teva Main Business
Table 78. Teva Latest Developments
Table 79. Teva Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Manufacturing Base, Sales Area and Its Competitors
Table 80. Bristol-Myers Squibb Product Offered
Table 81. Bristol-Myers Squibb Orally Disintegrating Tablet Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. Bristol-Myers Squibb Main Business
Table 83. Bristol-Myers Squibb Latest Developments
Table 84. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Product Offered
Table 86. Merck Orally Disintegrating Tablet Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Merck Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Product Offered
Table 91. Pfizer Orally Disintegrating Tablet Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Pfizer Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Manufacturing Base, Sales Area and Its Competitors
Table 95. Johnson and Johnson Product Offered
Table 96. Johnson and Johnson Orally Disintegrating Tablet Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 97. Johnson and Johnson Main Business
Table 98. Johnson and Johnson Latest Developments
Table 99. Johnson and Johnson Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Product Offered
Table 101. Mylan Orally Disintegrating Tablet Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Mylan Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Manufacturing Base, Sales Area and Its Competitors
Table 105. Eli Lilly and Company Product Offered
Table 106. Eli Lilly and Company Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Manufacturing Base, Sales Area and Its Competitors
Table 107. Eli Lilly and Company Main Business
Table 108. Eli Lilly and Company Latest Developments
Table 109. Eli Lilly and Company Orally Disintegrating Tablet Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 110. GSK Product Offered
Table 111. GSK Orally Disintegrating Tablet Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. GSK Main Business
Table 113. GSK Latest Developments
Table 114. GSK Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Manufacturing Base, Sales Area and Its Competitors
Table 115. AstraZeneca Product Offered
Table 116. AstraZeneca Orally Disintegrating Tablet Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 117. AstraZeneca Main Business
Table 118. AstraZeneca Latest Developments
Table 119. AstraZeneca Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Manufacturing Base, Sales Area and Its Competitors
Table 120. Otsuka Product Offered
Table 121. Otsuka Orally Disintegrating Tablet Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 122. Otsuka Main Business
Table 123. Otsuka Latest Developments
Table 124. Otsuka Basic Information, Company Total Revenue (in $ million), Orally Disintegrating Tablet Manufacturing Base, Sales Area and Its Competitors
Table 125. Conquer Product Offered
Table 126. Conquer Orally Disintegrating Tablet Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 127. Conquer Main Business
Table 128. Conquer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Conquer Latest Developments
List of Figures
Figure 1. Picture of Orally Disintegrating Tablet
Figure 2. Orally Disintegrating Tablet Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Orally Disintegrating Tablet Consumption Growth Rate 2015-2025 (M Units)
Figure 5. Global Orally Disintegrating Tablet Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Anti-Psychotics Drug
Figure 7. Product Picture of Anti-Epileptics Drug
Figure 8. Product Picture of Others
Figure 9. Global Orally Disintegrating Tablet Consumption Market Share by Type (2015-2020)
Figure 10. Global Orally Disintegrating Tablet Value Market Share by Type (2015-2020)
Figure 11. Orally Disintegrating Tablet Consumed in CNS Diseases
Figure 12. Global Orally Disintegrating Tablet Market: CNS Diseases (2015-2020) (M Units)
Figure 13. Global Orally Disintegrating Tablet Market: CNS Diseases (2015-2020) ($ Millions)
Figure 14. Orally Disintegrating Tablet Consumed in Gastrointestinal Diseases
Figure 15. Global Orally Disintegrating Tablet Market: Gastrointestinal Diseases (2015-2020) (M Units)
Figure 16. Global Orally Disintegrating Tablet Market: Gastrointestinal Diseases (2015-2020) ($ Millions)
Figure 17. Orally Disintegrating Tablet Consumed in CVS Diseases
Figure 18. Global Orally Disintegrating Tablet Market: CVS Diseases (2015-2020) (M Units)
Figure 19. Global Orally Disintegrating Tablet Market: CVS Diseases (2015-2020) ($ Millions)
Figure 20. Orally Disintegrating Tablet Consumed in Others
Figure 21. Global Orally Disintegrating Tablet Market: Others (2015-2020) (M Units)
Figure 22. Global Orally Disintegrating Tablet Market: Others (2015-2020) ($ Millions)
Figure 23. Global Orally Disintegrating Tablet Consumption Market Share by Application (2015-2020)
Figure 24. Global Orally Disintegrating Tablet Value Market Share by Application (2015-2020)
Figure 25. Global Orally Disintegrating Tablet Sales Market Share by Company in 2017
Figure 26. Global Orally Disintegrating Tablet Sales Market Share by Company in 2019
Figure 27. Global Orally Disintegrating Tablet Revenue Market Share by Company in 2017
Figure 28. Global Orally Disintegrating Tablet Revenue Market Share by Company in 2019
Figure 29. Global Orally Disintegrating Tablet Sale Price by Company in 2019
Figure 30. Global Orally Disintegrating Tablet Consumption Market Share by Regions 2015-2020
Figure 31. Global Orally Disintegrating Tablet Value Market Share by Regions 2015-2020
Figure 32. Americas Orally Disintegrating Tablet Consumption 2015-2020 (M Units)
Figure 33. Americas Orally Disintegrating Tablet Value 2015-2020 ($ Millions)
Figure 34. APAC Orally Disintegrating Tablet Consumption 2015-2020 (M Units)
Figure 35. APAC Orally Disintegrating Tablet Value 2015-2020 ($ Millions)
Figure 36. Europe Orally Disintegrating Tablet Consumption 2015-2020 (M Units)
Figure 37. Europe Orally Disintegrating Tablet Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Orally Disintegrating Tablet Consumption 2015-2020 (M Units)
Figure 39. Middle East & Africa Orally Disintegrating Tablet Value 2015-2020 ($ Millions)
Figure 40. Americas Orally Disintegrating Tablet Consumption Market Share by Countries in 2019
Figure 41. Americas Orally Disintegrating Tablet Value Market Share by Countries in 2019
Figure 42. Americas Orally Disintegrating Tablet Consumption Market Share by Type in 2019
Figure 43. Americas Orally Disintegrating Tablet Consumption Market Share by Application in 2019
Figure 44. United States Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 45. United States Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 47. Canada Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 49. Mexico Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Orally Disintegrating Tablet Consumption Market Share by Countries in 2019
Figure 51. APAC Orally Disintegrating Tablet Value Market Share by Regions in 2019
Figure 52. APAC Orally Disintegrating Tablet Consumption Market Share by Type in 2019
Figure 53. APAC Orally Disintegrating Tablet Consumption Market Share by Application in 2019
Figure 54. China Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 55. China Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 57. Japan Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 59. Korea Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 61. Southeast Asia Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 62. India Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 63. India Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 65. Australia Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Orally Disintegrating Tablet Consumption Market Share by Countries in 2019
Figure 67. Europe Orally Disintegrating Tablet Value Market Share by Countries in 2019
Figure 68. Europe Orally Disintegrating Tablet Consumption Market Share by Type in 2019
Figure 69. Europe Orally Disintegrating Tablet Consumption Market Share by Application in 2019
Figure 70. Germany Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 71. Germany Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 72. France Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 73. France Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 74. UK Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 75. UK Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 77. Italy Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 79. Russia Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Orally Disintegrating Tablet Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Orally Disintegrating Tablet Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Orally Disintegrating Tablet Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Orally Disintegrating Tablet Consumption Market Share by Application in 2019
Figure 84. Egypt Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 85. Egypt Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 87. South Africa Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 89. Israel Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 91. Turkey Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Orally Disintegrating Tablet Consumption Growth 2015-2020 (M Units)
Figure 93. GCC Countries Orally Disintegrating Tablet Value Growth 2015-2020 ($ Millions)
Figure 94. Global Orally Disintegrating Tablet Consumption Growth Rate Forecast (2021-2025) (M Units)
Figure 95. Global Orally Disintegrating Tablet Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 97. Americas Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 98. APAC Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 99. APAC Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 100. Europe Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 101. Europe Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 103. Middle East & Africa Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 104. United States Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 105. United States Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 106. Canada Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 107. Canada Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 108. Mexico Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 109. Mexico Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 110. Brazil Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 111. Brazil Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 112. China Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 113. China Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 114. Japan Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 115. Japan Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 116. Korea Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 117. Korea Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 119. Southeast Asia Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 120. India Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 121. India Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 122. Australia Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 123. Australia Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 124. Germany Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 125. Germany Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 126. France Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 127. France Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 128. UK Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 129. UK Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 130. Italy Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 131. Italy Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 132. Russia Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 133. Russia Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 134. Spain Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 135. Spain Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 136. Egypt Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 137. Egypt Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 138. South Africa Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 139. South Africa Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 140. Israel Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 141. Israel Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 142. Turkey Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 143. Turkey Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Orally Disintegrating Tablet Consumption 2021-2025 (M Units)
Figure 145. GCC Countries Orally Disintegrating Tablet Value 2021-2025 ($ Millions)
Figure 146. Teva Orally Disintegrating Tablet Market Share (2018-2020)
Figure 147. Bristol-Myers Squibb Orally Disintegrating Tablet Market Share (2018-2020)
Figure 148. Merck Orally Disintegrating Tablet Market Share (2018-2020)
Figure 149. Pfizer Orally Disintegrating Tablet Market Share (2018-2020)
Figure 150. Johnson and Johnson Orally Disintegrating Tablet Market Share (2018-2020)
Figure 151. Mylan Orally Disintegrating Tablet Market Share (2018-2020)
Figure 152. Eli Lilly and Company Orally Disintegrating Tablet Market Share (2018-2020)
Figure 153. GSK Orally Disintegrating Tablet Market Share (2018-2020)
Figure 154. AstraZeneca Orally Disintegrating Tablet Market Share (2018-2020)
Figure 155. Otsuka Orally Disintegrating Tablet Market Share (2018-2020)
Figure 156. Conquer Orally Disintegrating Tablet Market Share (2018-2020)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets